Genmab — April 2025
-
Enig @concillado Det er det eneste der giver mening. Det var såmænd blot for at give det lidt perspektiv. Aktien har så sandelig også brug for støtteindkøb. Hvad angår toldsatserne så tror jeg at Trump taber den her til kongressen da det er et spørgsmål om at folk skal genvælges, og at en masse mennesker (middelklassen såvel som velhavere) taber en masse penge lige nu.
-
@nohope At Genmab følger et regelsæt fremgår direkte af det link som E L postede i går 14:06.
-
@JKY_VH: Var aktiekøbet ikke kun på ca. 2.000mio?
-
Tak... huskede blot de "2mio"-agtigt i beskrivelsen
-
...men det kommer næsten også ud på det samme, når kursen nu nærmer sig de 1000

-
Trump & co. skraldgriner i skyggerne, når de ophæver hele tolddynen og har fået købt billige aktier for alle de russiske skyggereserver

-
...et skridt nærmere til det endelige amerikanske oligarki.
-
Wainwright -Genmab’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Despite Minor Setbacks https://www.tipranks.com/news/ratings/genmabs-strong-financial-performance-and-strategic-positioning-justify-buy-rating-despite-minor-setbacks
-
Very true. The news on potential tariffs on pharmaceuticals obviously hitting euro pharma and biotech hard today. One could argue though that, for the next few years, Genmab is actually not in such a bad position on this subject as for the drugs that currently make them money, they partner with giant pharma that have access to US production facilities.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
